Cancer Treatment Centers of America: Clincal Trials
Learn More About This Topic: Chat with Us | Email Us
Compassionate Use of Omegaven® in the Treatment of Parenteral Nutrition Induced Hepatic Injury
Summary
This study is for patients who are receiving intravenous or IV Parenteral nutrition and have worsening liver disease. It will make Omegaven® available to cancer patients with liver disease and assess the effect of Omegaven® on liver disease.
For More Information:
Please contact one of our Oncology Information Specialists at 1-800-615-3055 to learn more about this clinical trial. Oncology Information Specialists are available 24 hours a day, 7 days a week, 365 days a year.
